UCB Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:UCB Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014079
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UCB Inc (UCB), a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metadate CD, and others. UCB’s products are used in the treatment of partial onset seizures, rheumatoid arthritis, attention deficit hyperactivity disorder and cough and upper respiratory symptoms associated with allergy or a cold. The company also conducts research and development to upgrade its products according to market requirements. It offers several health programs for patients, healthcare professionals and caregivers. The company operates through research triangle park located in North Carolina. UCB is headquartered in Smyrna, Georgia, the US.

UCB Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UCB Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
UCB Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
UCB Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
UCB Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
UCB Inc, Medical Devices Deals, 2011 to YTD 2017 9
UCB Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
UCB Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Clementia Pharma Secures USD60 Million Venture Financing 11
Partnerships 13
Evotec Partners with UCB 13
Vectura Enters Into Co-Development Agreement With UCB For Biologic Immunomodulatory Product 14
UCB Enters Into Research Collaboration With Katholieke Universiteit Leuven 15
UCB Enters Into Co-Development Agreement With Harvard University 16
Licensing Agreements 17
UCB Exercises Option for Licensing Agreement with Oncodesign 17
UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 18
UCB Inc – Key Competitors 19
UCB Inc – Key Employees 20
UCB Inc – Locations And Subsidiaries 21
Head Office 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
UCB Inc, Pharmaceuticals & Healthcare, Key Facts 2
UCB Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
UCB Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
UCB Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
UCB Inc, Deals By Therapy Area, 2011 to YTD 2017 8
UCB Inc, Medical Devices Deals, 2011 to YTD 2017 9
UCB Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Clementia Pharma Secures USD60 Million Venture Financing 11
Evotec Partners with UCB 13
Vectura Enters Into Co-Development Agreement With UCB For Biologic Immunomodulatory Product 14
UCB Enters Into Research Collaboration With Katholieke Universiteit Leuven 15
UCB Enters Into Co-Development Agreement With Harvard University 16
UCB Exercises Option for Licensing Agreement with Oncodesign 17
UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 18
UCB Inc, Key Competitors 19
UCB Inc, Key Employees 20

★海外企業調査レポート[UCB Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nightstar Therapeutics PLC (NITE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nightstar Therapeutics PLC (Nightstar Therapeutics), formerly Nightstar Therapeutics Ltd, is a clinical-stage gene therapy company. The company focus on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. Its lead product cand …
  • Allied World Assurance Company Holdings, GmbH:企業の戦略・SWOT・財務情報
    Allied World Assurance Company Holdings, GmbH - Strategy, SWOT and Corporate Finance Report Summary Allied World Assurance Company Holdings, GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Nautilus Minerals Inc.:企業のM&A・事業提携・投資動向
    Nautilus Minerals Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nautilus Minerals Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Sucrerie Couplet SA:企業の戦略・SWOT・財務分析
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Meridian Bioscience Inc (VIVO)-製薬・医療分野:企業M&A・提携分析
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • Knoll, Inc.:戦略・SWOT・企業財務分析
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Insys Therapeutics Inc (INSY)-製薬・医療分野:企業M&A・提携分析
    Summary Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems. The company’s flagship product, Subsys is a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients. Its lead prod …
  • State Grid Corporation of China:電力:M&Aディール及び事業提携情報
    Summary State Grid Corporation of China (SGCC) is an electric utility that builds and operates power grids, and distributes and transmits electricity. The utility offers energy efficient home appliances air conditioner, fan, TV set, washing machine, microwave oven, refrigerator, electric water heate …
  • Ontario Power Generation Inc:企業の戦略的SWOT分析
    Ontario Power Generation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Tradewinds Corporation Berhad:戦略・SWOT・企業財務分析
    Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Tradewinds Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Power Finance Corporation Ltd.:企業の戦略・SWOT・財務情報
    Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Power Finance Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Venator Materials PLC (VNTR):企業の財務・戦略的SWOT分析
    Venator Materials PLC (VNTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Nasser S. Al –Hajri Corp:企業の戦略的SWOT分析
    Nasser S. Al –Hajri Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Amkor Technology Inc (AMKR):企業の財務・戦略的SWOT分析
    Amkor Technology Inc (AMKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Akari Therapeutics Plc (AKTX):企業の財務・戦略的SWOT分析
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company. The company is engaged in the development of therapeutic treatments for rare and orphan autoimmune and inflammatory diseases. It offers coversin drugs that act on complement component-C5 that hel …
  • Integrated DNA Technologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Integrated DNA Technologies Inc (IDT) is a biotechnology company that develops diagnostic test products. The company’s products include DNA and RNA synthesis, genotyping, modifications, nextgen sequencing, gene silencing, synthesis genes, and purifications, among others. It offers services s …
  • Westinghouse Electric Co LLC:企業の戦略的SWOT分析
    Westinghouse Electric Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Fluxion Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical and live cell analysis tools. The company’s products include IsoFlux system and CTC kits, BioFlux System, IonFlux System, Cytation CTC imager and enumeration kits, and sequencing kits. It provides analytical services for a range o …
  • ARK Diagnostics Inc:企業の製品パイプライン分析
    Summary ARK Diagnostics Inc (ARK Diagnostics) is a developer, manufacturer and commercializer of in vitro diagnostic immunoassay products. The company's products include protease inhibitors, levetiracetam assay, topiramate assay, non-nucleoside reverse transcriptase inhibitors, gabapentin assay, lam …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆